VeriSign Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (VRSN-NASDAQ) SUMMARY
|
|
- Maria Lawrence
- 5 years ago
- Views:
Transcription
1 September 19, 2013 VeriSign Inc. Current Recommendation Prior Recommendation SUMMARY DATA NEUTRAL Outperform Date of Last Change 06/24/2013 Current Price (09/18/13) $51.30 Target Price $ Week High $ Week Low $34.15 One-Year Return (%) 8.57 Beta 0.86 Average Daily Volume (sh) 1,145,113 Shares Outstanding (mil) 144 Market Capitalization ($mil) $7,366 Short Interest Ratio (days) Institutional Ownership (%) N/A Insider Ownership (%) 1 Annual Cash Dividend $0.00 Dividend Yield (%) Yr. Historical Growth Rates Sales (%) -7.0 Earnings Per Share (%) 18.6 Dividend (%) N/A using TTM EPS 24.4 using 2013 Estimate 23.6 using 2014 Estimate 21.0 Zacks Rank *: Short Term 1 3 months outlook * Definition / Disclosure on last page 3 - Hold SUMMARY Risk Level * Type of Stock (VRSN-NASDAQ) VeriSign s second quarter results beat the Zacks Consensus Estimate on both lines. Management provided a positive guidance based on higher addition of new names in the registry. We believe that the hike in.net fees will drive the company s topline growth going forward. Additionally, growing generic top-level domain customer base, international expansion through IDNs and strong growth in the Network Intelligence and Availability services will further boost revenues and profitability. However, negative impact of search engine adjustments on domain monetization and increasing marketing expenses related to the introduction of new gtlds and IDNs remain the primary headwinds in the near term. Moreover, the ongoing cash repatriation issue remains a concern with respect to liquidity in the near term. Although the recent debt issue improves liquidity, we believe that higher interest rates will hurt profitability in the near term. Additionally, significant competition in the NIA segment remains a concern. Thus, we remain Neutral and set a price target of $ Low, N/A Industry Internet Softwa Zacks Industry Rank * 19 out of 267 ZACKS CONSENSUS ESTIMATES Revenue Estimates (In millions of $) Q1 Q2 Q3 Q4 Year (Mar) (Jun) (Sep) (Dec) (Dec) A 190 A 197 A 204 A 773 A A 214 A 224 A 230 A 874 A A 239 A 241 E 244 E 961 E E 254 E 1,022 E Earnings Per Share Estimates (EPS is operating earnings before non-recurring items, but including employee stock options expenses) Q1 Q2 Q3 Q4 Year (Mar) (Jun) (Sep) (Dec) (Dec) 2011 $0.27 A $0.32 A $0.37 A $0.35 A $1.31 A 2012 $0.41 A $0.43 A $0.46 A $0.54 A $1.84 A 2013 $0.55 A $0.55 A $0.53 E $0.54 E $2.17 E 2014 $0.60 E $0.62 E $2.44 E Projected EPS Growth - Next 5 Years % Zacks Investment Research, All Rights reserved North Canal Street, Chicago IL 60606
2 OVERVIEW Based in Reston, Calif., VeriSign Inc. (VRSN) provides Internet infrastructure services that include domain name registry services and infrastructure assurance services. Through its only reportable segment Naming Services, the company provides Registry services and Network Intelligence and Availability (NIA) services. Registry services operate the authoritative directory of.com,.net,.cc,.tv, and.name domain names. With respect to the.com,.net and.name, the company has agreements with the Internet Corporation for Assigned Names and Numbers (ICANN) that makes it the exclusive register of these domain names. With respect to.com the company has an agreement with the U. S. Department of Commerce (DOC). In Jun 2012, ICANN approved the renewal of the company's agreement to serve as the authoritative registry operator for the.com registry. The term period for the agreement started from Dec 1, 2012 through Nov 30, Subsequently, in Nov 2012, DOC also approved VeriSign s renewal agreement with ICANN. Besides ICANN, the company has agreements that make it the exclusive registry for the.tv and.cc country code top-level domains (cctlds). Additionally, the company provides back-end systems for all.gov,.jobs and.edu domain names based on these agreements. It also provides internationalized domain name (IDN) services that enable web-users to access websites in their local language. VeriSign charges fees for operating different domain names except.edu registry. The.com and.net fees are charged as per agreement terms with ICANN and any price increase is subject to prior approval of the DOC for the.com domain. The.name fees are charged as per terms of agreement with ICAAN, while fees received for operating the.gov registry are based on the terms of agreement with the U.S. General Services Administration ( GSA ). NIA provides infrastructure assurance services to organizations and also offers idefense, Managed Domain Name System and Distributed Denial of Service protection Services. VeriSign reported revenues of $873.6 million in Active domain names ending with.com and.net were million at the end of Mar 31, US contributed 64.8% of revenues, while Europe, the Middle East and Africa (EMEA), Australia, China, India, and other Asia Pacific countries (APAC) and other countries (that include Canada and Latin American countries) contributed 15.5%, 15.0% and 4.7% respectively. VeriSign faces competition in the domain name registry market from 16 registries for the operation of 18 generic top-level domains (gtlds) who have agreements with ICANN. The company also competes with more than 250 Latin script cctld registries and 38 IDN cctld registries as well as from outsourced domain name service providers such as Neustar, Inc., Afilias Limited, ARI Registry Services and Nominet UK, Inc. The company also competes with search engine providers such as Google, Microsoft and Yahoo! and social networking services provider Facebook. Equity Research VRSN Page 2
3 REASONS TO BUY We believe that the renewal of the.com contract and price hike for the.com and.net domain name registration will boost VeriSign s top-line growth going forward. In 2012, the company hiked the registry fee for both.com and.net domain. The company hiked.com fees by 7% ($0.51) to $7.85 and.net fees by 10.0% ($0.51) to $5.62. Although the.com price is expected to remain fixed till Nov 30, 2018 (as per its agreement with ICANN), the company has the right to increase.net domain fees by up to 10% each year till Jun 30, During the second quarter, the company raised.net domain fee by $0.56 to $6.18, effective Feb 1, We believe that frequent increases in fees provide a significant growth opportunity for the company going forward. VeriSign views the introduction of new gtlds as an adjacent growth opportunity. The company has applied for 14 new gtlds including 12 IDNs (internationalized domain names). In addition, applicants for approximately 220 new gtlds have already selected the company to provide backend registry services. Additionally, international expansion through IDNs will also boost its penetration rate into the growing markets of APAC. We believe that along with price increases this will positively impact results over the long term. We remain particularly optimistic on VeriSign s Network Intelligence and Availability ( NIA ) services business. With the rapid adoption of cloud computing, cyber security has become a major concern for enterprises. Large enterprises are expected to increase their security budgets to efficiently address security concerns and renew confidence in cloud computing. According to market research firm Gartner, the global market for cyber security will reach $86.0 billion by We believe that the company s NIA business continues to gain traction and this huge spending will provide it a significant growth opportunity going forward. VeriSign has a healthy cash balance ($2.0 billion) and remains committed on increasing shareholder value through share repurchases and dividends. In the first half of 2013, the company repurchased 10.1 million shares for $465.9 million. At the end of Jun 30, 2013, the company had approximately $1.00 billion ($509.7 million under 2012 plan and $519.0 million authorization announced recently) remaining under its current share repurchase program. Moreover, the company continues to generate significant cash flow ($297.5 million in the first half of 2013), which will help it to pursue further growth opportunities including acquisitions going forward. REASONS TO SELL Under the agreement with ICANN, VeriSign is subject to certain restrictions in the operation of.com,.net and.name domains on pricing, bundling and use of registrars. However, these restrictions do not apply to cctlds. The introduction of new IDN TLDs and gtlds by ICANN will further intensify competition. An increase in domain name availability in the marketplace could introduce new choices for end-users as well as create end-user confusion around brand preference, which, in turn, could have an adverse effect on the company s business. Another significant headwind for VeriSign is the sluggish growth in the active domain name business for.com and.net TLDs. Net new name registrations declined from 8.6 million in 2011 to 7.3 million in The company has cited search algorithm changes from Google and macro-economic headwinds in Europe as the primary factors behind these declines. Google s free public domain name service is also a major competitor in our view. We believe lower first time renewal rates will continue to hurt top-line growth going forward. Equity Research VRSN Page 3
4 VeriSign s balance sheet is significantly leveraged. As of Jun 30, 2013, the company had a total debt obligation of $2.0 billion, which includes the new $750.0 million debt issuance and $1.25 billion subordinated convertible debenture. Higher interest rate on its debt is also expected to negatively impact profitability going forward. VeriSign holds approximately 85.0% of its cash balance internationally. Currently, the company is in the process of evaluating strategic alternatives related to repatriation of this large cash balance. According to management, the process is significantly complex and it expects to provide an update by the end of this year. Unless the repatriation analysis is complete, we believe that concerns regarding near-term liquidity will linger. Although the recent debt issue improves liquidity, higher interest rate will hurt profitability. We provide a word of caution to investors in this regard. RECENT NEWS Second Quarter Highlights Jul 25 VeriSign reported second-quarter 2013 earnings of $0.55 per share, which beat the Zacks Consensus Estimate by $0.02. Earnings (minus stock-based compensation) increased 22.5% year over year but declined 4.6% sequentially. Revenues surged 11.8% year over year and 1.2% sequentially to $239.3 million, slightly ahead of the Zacks Consensus Estimate of $237.0 million. Approximately 60% of the revenues were from the U.S, while the remaining came from overseas. Both U.S. and international revenues increased 12.0% from the year-ago quarter. VeriSign Registry Services added 1.22 million net new names compared with 1.99 million in the previous quarter. Active domain names in the zone for.com and.net increased 4.9% year over year to $124.3 million (.com million and.net 15.1 million) in the quarter. VeriSign processed 8.7 million new domain name registrations for.com and.net, slightly down from 8.9 million in the year-ago quarter and 8.8 million in the previous quarter. VeriSign estimates renewal rate to be approximately 72.4% in the second quarter compared with 72.9% in the year-ago quarter. Exact renewal rate figures will be available post 45 days of the end of the quarter. In the first quarter of 2013, renewal rate was 73.2%. During the quarter, VeriSign hiked fee for.net domain names from $5.62 to $6.18, effective from Feb 1, 2014, as per its agreement with Internet Corporation for Assigned Names and Numbers (ICANN). As a percentage of revenues, operating expenses declined to 44.8% in the second quarter compared with 50.0% in the year-ago quarter but increased from 43.6% in the previous quarter. A sharp decline in sales & marketing (S&M) as well as general & administrative (G&A) expenses, down 260 basis points ( bps ) and 210 bps, respectively, drove the year-over-year decline. Research & development (R&D) expense declined a modest 10 bps from the year-ago quarter. The sequential rise in operating expense as a percentage of revenues was primarily due to a 20 bps expansion in G&A and a 200 bps upside in S&M, which offset a 60 bps decrease in R&D. Operating margin was 55.2% in the quarter, compared with 50.0% in the year-ago quarter and 59.6% in the previous quarter. The year-over-year improvement was primarily due to lower operating expenses. However, sharp rise in operating expenses on a sequential basis negatively impacted operating margin. Equity Research VRSN Page 4
5 Net income as percentage of revenues was 36.1% compared with 32.9% in the year-ago quarter and 37.9% in the previous quarter. Cash and cash equivalents (including marketable securities) were $2.00 billion (out of which $630.0 million was held in the U.S.) compared with $1.56 billion in the previous quarter. The significant rise in cash balance was primarily due to the issuance of 10-year $750.0 million senior unsecured notes in Apr Operating cash flow was $147.0 million in the quarter, down from $150.6 million in the first quarter. Free cash flow was $132.0 million compared with $145.0 million in the previous quarter. VeriSign repurchased approximately 7.1 million shares for $334.0 million in the quarter. The company s board of directors approved an additional $519.0 million to buy back shares, which brings the total authorization to $1.0 billion. Positive Guidance VeriSign intends to focus more on developing new revenue streams in The company expects to add 1.0 to 1.4 million net new names in the.com and.net registry for the third quarter of For full year 2013, VeriSign forecasts revenues in the range of $952.0 to $962.0 million (up from prior outlook of $945.0 to $960.0 million), which represents an annual growth rate of 9.0% to 10% (up from 8%). Non-GAAP gross margin is expected to be at least 80%, while operating margin is forecast to be between 58.0% and 59.0% (up from at least 57%). Interest expense and non-operating income, net is expected to be within the range of $60.0 $62.0 million for fiscal Capital expenditure is expected in the range of $60.0 million to $80.0 million for fiscal Equity Research VRSN Page 5
6 VALUATION VeriSign shares are trading at 24.4X TTM earnings, a discount to the peer group average of 65.9X and S&P 500 average of 17.3X. Given that the 24.4X TTM is significantly lower than the midpoint of the historical range of 18.0X to 38.9X TTM earnings, we believe that the shares have upside potential over the next 3-6 months. The stock is trading at 23.6X our 2013 earnings estimate, 78.5% discount to the peer group average of 109.7X, much greater than the average discount of 30.5% historically, indicating the possibility of further upward movement. However, VerSign is expected to generate earnings growth of just 11.0% over the next 5 years, significantly lower than the peer group average of 22.6%, which is expected to limit the upside. Additionally higher interest rate due to the recent debt offering will hurt profitability going forward. Therefore, we believe that the discount attributed to the shares is justified. We maintain our Neutral recommendation and set a target price of $54.00 (24.9X 2013 EPS). Key Indicators F1 F2 Est. 5-Yr EPS Gr% P/CF (TTM) (TTM) 5-Yr High (TTM) VeriSign Inc (VRSN) Yr Low (TTM) Industry Average S&P NetEase Inc (NTES) Smart Technologies Inc. (SMT) QIHOO 360 TECH (QIHU) TTM is trailing 12 months; F1 is 2013 and F2 is 2014, CF is operating cash flow P/B P/B P/B ROE D/E Div Yield EV/EBITDA Last 5-Yr High 5-Yr Low (TTM) Last Qtr. Last Qtr. (TTM) Qtr. VeriSign Inc (VRSN) Industry Average S&P N/A 2.1 N/A Equity Research VRSN Page 6
7 Earnings Surprise and Estimate Revision History Equity Research VRSN Page 7
8 StockResearchWiki.com The Online Stock Research Community Discover what other investors are saying about VeriSign Inc (VRSN) at StockResearchWiki.com: DISCLOSURES & DEFINITIONS The analysts contributing to this report do not hold any shares of VRSN. The EPS and revenue forecasts are the Zacks Consensus estimates. Additionally, the analysts contributing to this report certify that the views expressed herein accurately reflect the analysts personal views as to the subject securities and issuers. Zacks certifies that no part of the analysts compensation was, is, or will be, directly or indirectly, related to the specific recommendation or views expressed by the analyst in the report. Additional information on the securities mentioned in this report is available upon request. This report is based on data obtained from sources we believe to be reliable, but is not guaranteed as to accuracy and does not purport to be complete. Because of individual objectives, the report should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed herein are subject to change. This report is not to be construed as an offer or the solicitation of an offer to buy or sell the securities herein mentioned. Zacks or its officers, employees or customers may have a position long or short in the securities mentioned and buy or sell the securities from time to time. Zacks uses the following rating system for the securities it covers. Outperform- Zacks expects that the subject company will outperform the broader U.S. equity market over the next six to twelve months. Neutral- Zacks expects that the company will perform in line with the broader U.S. equity market over the next six to twelve months. Underperform- Zacks expects the company will under perform the broader U.S. Equity market over the next six to twelve months. The current distribution of Zacks Ratings is as follows on the 1031 companies covered: Outperform %, Neutral %, Underperform 5.9%. Data is as of midnight on the business day immediately prior to this publication. Our recommendation for each stock is closely linked to the Zacks Rank, which results from a proprietary quantitative model using trends in earnings estimate revisions. This model is proven most effective for judging the timeliness of a stock over the next 1 to 3 months. The model assigns each stock a rank from 1 through 5. Zacks Rank 1 = Strong Buy. Zacks Rank 2 = Buy. Zacks Rank 3 = Hold. Zacks Rank 4 = Sell. Zacks Rank 5 = Strong Sell. We also provide a Zacks Industry Rank for each company which provides an idea of the near-term attractiveness of a company s industry group. We have 264 industry groups in total. Thus, the Zacks Industry Rank is a number between 1 and 264. In terms of investment attractiveness, the higher the rank the better. Historically, the top half of the industries has outperformed the general market. In determining Risk Level, we rely on a proprietary quantitative model that divides the entire universe of stocks into five groups, based on each stock s historical price volatility. The first group has stocks with the lowest values and are deemed Low Risk, while the 5 th group has the highest values and are designated High Risk. Designations of Below-Average Risk, Average Risk, and Above-Average Risk correspond to the second, third, and fourth groups of stocks, respectively. Equity Research VRSN Page 8
Itron, Inc. UNDERPERFORM ZACKS CONSENSUS ESTIMATES (ITRI-NASDAQ) SUMMARY
February 13, 2015 Itron, Inc. Current Recommendation Prior Recommendation Neutral Date of Last Change 02/08/2015 Current Price (02/12/15) $35.87 Target Price $33.00 SUMMARY DATA UNDERPERFORM 52-Week High
More informationAvon Products Inc. UNDERPERFORM ZACKS CONSENSUS ESTIMATES (AVP-NYSE)
February 19, 2015 Avon Products Inc. Current Recommendation Prior Recommendation Neutral Date of Last Change 02/19/2015 Current Price (02/18/15) $9.10 Target Price $8.25 SUMMARY DATA UNDERPERFORM 52-Week
More informationCincinnati Financial Corp.
February 06, 2015 Cincinnati Financial Corp. NEUTRAL Current Recommendation Prior Recommendation Outperform Date of Last Change 02/10/2014 Current Price (02/05/15) $51.89 Target Price $54.00 (CINF-NASDAQ)
More informationDENTSPLY International Inc.
March 18, 2015 DENTSPLY International Inc. Current Recommendation Prior Recommendation NEUTRAL Outperform Date of Last Change 02/19/2012 Current Price (03/17/15) $51.13 Target Price $54.00 SUMMARY (XRAY-NASDAQ)
More informationSUMMARY. Risk Level *
February 26, 2015 The Home Depot, Inc. Current Recommendation Earnings Update: Home Depot Tops Q4 Earnings & Revenues, Guides FY15 SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change
More informationAvery Dennison Corporation
March 20, 2015 Avery Dennison Corporation Current Recommendation NEUTRAL Prior Recommendation Outperform Date of Last Change 09/26/2013 Current Price (03/19/15) $53.00 Target Price $56.00 SUMMARY DATA
More informationLiberty Interactive Corporation
September 11, 2014 Liberty Interactive Corporation (LINTA-NASDAQ) Current Recommendation Prior Recommendation Neutral Date of Last Change 09/11/2014 Current Price (09/10/14) $29.41 Target Price $27.00
More informationSUMMARY. Risk Level *
February 13, 2015 NetApp, Inc. Current Recommendation Earnings Update: NetApp Reports Q3 Results SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 08/19/2013 Current Price (02/12/15)
More informationAvnet, Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (AVT-NYSE) SUMMARY
January 30, 2015 Avnet, Inc. Current Recommendation Prior Recommendation SUMMARY DATA NEUTRAL Underperform Date of Last Change 04/02/2013 Current Price (01/29/15) $42.26 Target Price $44.00 52-Week High
More informationVistaprint N.V. NEUTRAL ZACKS CONSENSUS ESTIMATES (VPRT-NASDAQ) SUMMARY
October 30, 2014 Vistaprint N.V. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 08/07/2013 Current Price (10/29/14) $55.06 Target Price $58.00 52-Week High
More informationSUMMARY. Risk Level *
January 09, 2015 Fred s Inc (FRED-NASDAQ) Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 07/17/2014 Current Price (01/08/15) $17.13 Target Price $18.00
More informationSVB Financial Group NEUTRAL ZACKS CONSENSUS ESTIMATES (SIVB-NASDAQ) SUMMARY
January 02, 2015 SVB Financial Group Current Recommendation NEUTRAL Prior Recommendation Outperform Date of Last Change 01/02/2015 Current Price (01/01/15) $116.07 Target Price $122.00 SUMMARY DATA (SIVB-NASDAQ)
More informationCullen/Frost Bankers, Inc.
December 26, 2014 Cullen/Frost Bankers, Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Neutral Date of Last Change 11/30/2001 Current Price (12/25/14) $70.74 Target Price $74.00
More information(PGR-NYSE) Risk Level *
March 18, 2015 Progressive Corp. Current Recommendation NEUTRAL Prior Recommendation Outperform Date of Last Change 05/19/2013 Current Price (03/17/15) $27.03 Target Price $28.00 SUMMARY DATA (PGR-NYSE)
More information(RHI-NYSE) SUMMARY. Risk Level *
March 04, 2015 Robert Half International Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 08/19/2012 Current Price (03/03/15) $62.70 Target Price $66.00
More information(SEIC-NASDAQ) Risk Level *
March 20, 2015 SEI Investments Co. Current Recommendation NEUTRAL Prior Recommendation Outperform Date of Last Change 09/30/2013 Current Price (03/19/15) $43.74 Target Price $46.00 SUMMARY DATA (SEIC-NASDAQ)
More informationPrudential Financial Inc.
February 06, 2015 Prudential Financial Inc. Current Recommendation NEUTRAL Prior Recommendation Outperform Date of Last Change 04/03/2014 Current Price (02/05/15) $75.32 Target Price $79.00 SUMMARY DATA
More informationInvesco Ltd. NEUTRAL ZACKS CONSENSUS ESTIMATES (IVZ-NYSE)
March 10, 2015 Invesco Ltd. (IVZ-NYSE) Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 10/03/2012 Current Price (03/09/15) $40.40 Target Price $42.00 52-Week
More informationRockwell Automation Inc.
March 16, 2015 Rockwell Automation Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 07/31/2011 Current Price (03/13/15) $111.52 Target Price $117.00
More informationJones Lang LaSalle Inc.
February 13, 2015 Jones Lang LaSalle Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 11/07/2013 Current Price (02/12/15) $160.97 Target Price $169.00
More informationPentair plc NEUTRAL ZACKS CONSENSUS ESTIMATES (PNR-NYSE)
March 20, 2015 Pentair plc (PNR-NYSE) Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 01/12/2014 Current Price (03/19/15) $64.38 Target Price $68.00 52-Week
More informationTorchmark Corp. NEUTRAL ZACKS CONSENSUS ESTIMATES (TMK-NYSE) SUMMARY
March 12, 2015 Torchmark Corp. Current Recommendation NEUTRAL Prior Recommendation Underperform Date of Last Change 07/20/2006 Current Price (03/11/15) $53.41 Target Price $56.00 SUMMARY DATA (TMK-NYSE)
More informationAllscripts Healthcare Solutions, Inc.
December 01, 2014 Allscripts Healthcare Solutions, Inc. Current Recommendation Prior Recommendation SUMMARY DATA NEUTRAL Outperform Date of Last Change 05/17/2012 Current Price (11/28/14) $12.02 Target
More informationCH Robinson Worldwide Inc.
March 20, 2015 CH Robinson Worldwide Inc. Current Recommendation NEUTRAL Prior Recommendation Underperform Date of Last Change 08/22/2013 Current Price (03/19/15) $75.16 Target Price $79.00 SUMMARY DATA
More informationPitney Bowes Inc. (PBI-NYSE) Analyst Note
February 03, 2015 Pitney Bowes Inc. (PBI-NYSE) Analyst Note Current Recommendation Prior Recommendation Outperform Date of Last Change 05/01/2014 Current Price (02/02/15) $22.26 Target Price $23.00 NEUTRAL
More informationDeere & Company NEUTRAL ZACKS CONSENSUS ESTIMATES (DE-NYSE)
February 13, 2015 Deere & Company Current Recommendation Prior Recommendation Outperform Date of Last Change 12/09/2010 Current Price (02/12/15) $89.37 Target Price $94.00 NEUTRAL (DE-NYSE) SUMMARY Deere
More informationThe Tjx Companies Inc
February 26, 2015 The Tjx Companies Inc Current Recommendation Prior Recommendation Underperform Date of Last Change 04/29/2010 Current Price (02/25/15) $69.38 Target Price $73.00 NEUTRAL SUMMARY (TJX-NYSE)
More informationKirkland s Inc OUTPERFORM ZACKS CONSENSUS ESTIMATES (KIRK-NASDAQ) SUMMARY
February 09, 2015 Kirkland s Inc (KIRK-NASDAQ) Current Recommendation Prior Recommendation Neutral Date of Last Change 02/09/2015 Current Price (02/06/15) $25.66 Target Price $31.00 OUTPERFORM SUMMARY
More informationLincoln Electric Holdings Inc.
January 22, 2015 Lincoln Electric Holdings Inc. Current Recommendation Prior Recommendation Neutral Date of Last Change 01/22/2015 Current Price (01/21/15) $67.15 Target Price $81.00 OUTPERFORM SUMMARY
More informationDover Corporation NEUTRAL ZACKS CONSENSUS ESTIMATES (DOV-NYSE) SUMMARY
March 09, 2015 Dover Corporation Current Recommendation Prior Recommendation Outperform Date of Last Change 01/11/2011 Current Price (03/06/15) $70.71 Target Price $74.00 NEUTRAL SUMMARY (DOV-NYSE) In
More informationHibbett Sports, Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (HIBB-NASDAQ)
December 12, 2014 Hibbett Sports, Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 06/17/2014 Current Price (12/11/14) $48.16 Target Price $51.00 52-Week
More informationAGCO Corporation NEUTRAL ZACKS CONSENSUS ESTIMATES (AGCO-NYSE) SUMMARY
February 05, 2015 AGCO Corporation Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 12/28/2014 Current Price (02/03/15) $48.96 Target Price $51.00 52-Week
More informationAmerican Axle & Manufacturing Holdings Inc.
January 22, 2015 American Axle & Manufacturing Holdings Inc. (AXL-NYSE) NEUTRAL Current Recommendation Prior Recommendation Underperform Date of Last Change 05/07/2013 Current Price (01/21/15) $24.14 Target
More informationMagna International Inc.
February 26, 2015 Magna International Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 07/09/2014 Current Price (02/25/15) $110.01 Target Price $116.00
More informationFederated Investors, Inc.
March 04, 2015 Federated Investors, Inc. Current Recommendation Prior Recommendation Underperform Date of Last Change 11/30/2014 Current Price (03/03/15) $33.52 Target Price $35.00 NEUTRAL SUMMARY (FII-NYSE)
More informationThe Cheesecake Factory Incorporated
March 20, 2015 The Cheesecake Factory Incorporated (CAKE-NASDAQ) Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 01/12/2011 Current Price (03/19/15) $48.82
More informationWells Fargo & Company
March 04, 2015 Wells Fargo & Company Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation N/A Date of Last Change 04/07/2000 Current Price (03/03/15) $55.45 Target Price $58.00 52-Week High
More informationCRA International Inc.
February 27, 2015 CRA International Inc. Current Recommendation Prior Recommendation Outperform Date of Last Change 02/09/2015 Current Price (02/26/15) $30.11 Target Price $32.00 NEUTRAL (CRAI-NASDAQ)
More informationO'Reilly Automotive Inc.
February 05, 2015 O'Reilly Automotive Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 06/15/2011 Current Price (02/03/15) $193.28 Target Price $203.00
More informationHSBC Holdings plc ADR (HSBC-NYSE)
February 24, 2015 HSBC Holdings plc ADR (HSBC-NYSE) Analyst Note NEUTRAL Current Recommendation Prior Recommendation Outperform Date of Last Change 12/21/2014 Current Price (02/23/15) $44.68 Target Price
More informationCIT Group Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (CIT-NYSE)
February 24, 2015 CIT Group Inc. (CIT-NYSE) Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 02/18/2015 Current Price (02/23/15) $46.13 Target Price $48.50
More informationCablevision Systems Corporation.
January 14, 2015 Cablevision Systems Corporation. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 02/10/2014 Current Price (01/13/15) $20.00 Target Price
More informationThe Clorox Company NEUTRAL ZACKS CONSENSUS ESTIMATES (CLX-NYSE)
March 11, 2015 The Clorox Company Current Recommendation NEUTRAL Prior Recommendation Outperform Date of Last Change 11/11/2012 Current Price (03/10/15) $107.83 Target Price $113.00 SUMMARY DATA (CLX-NYSE)
More informationCanadian Natural Resources Ltd.
March 12, 2015 Canadian Natural Resources Ltd. (CNQ-NYSE) Current Recommendation Prior Recommendation Underperform Date of Last Change 06/30/2013 Current Price (03/11/15) $28.82 Target Price $30.00 NEUTRAL
More informationAmerican Capital Agency Corp.
January 15, 2015 American Capital Agency Corp. (AGNC-NASDAQ) Current Recommendation Prior Recommendation Neutral Date of Last Change 10/15/2014 Current Price (01/14/15) $21.53 Target Price $26.00 SUMMARY
More informationCharter Communications Inc.
December 12, 2014 Charter Communications Inc. Current Recommendation NEUTRAL Prior Recommendation Underperform Date of Last Change 02/26/2014 Current Price (12/11/14) $164.16 Target Price $172.00 SUMMARY
More informationMeritor, Inc. OUTPERFORM ZACKS CONSENSUS ESTIMATES (MTOR-NYSE)
January 08, 2015 Meritor, Inc. Current Recommendation Prior Recommendation Neutral Date of Last Change 01/08/2015 Current Price (01/07/15) $15.10 Target Price $18.00 SUMMARY DATA OUTPERFORM 52-Week High
More informationAkamai Technologies Inc.
February 19, 2015 Akamai Technologies Inc. Current Recommendation Prior Recommendation Outperform Date of Last Change 12/22/2013 Current Price (02/18/15) $70.29 Target Price $74.00 NEUTRAL SUMMARY (AKAM-NASDAQ)
More informationBig Lots Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (BIG-NYSE) SUMMARY
March 13, 2015 Big Lots Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 03/24/2014 Current Price (03/11/15) $49.95 Target Price $52.00 52-Week High
More informationUltra Petroleum Corp.
January 21, 2015 Ultra Petroleum Corp. Current Recommendation Prior Recommendation Neutral Date of Last Change 11/16/2014 Current Price (01/20/15) $13.57 Target Price $12.00 SUMMARY DATA UNDERPERFORM 52-Week
More informationTerex Corporation NEUTRAL ZACKS CONSENSUS ESTIMATES (TEX-NYSE) SUMMARY
February 19, 2015 Terex Corporation Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 01/04/2015 Current Price (02/18/15) $26.80 Target Price $28.00 52-Week
More informationInterpublic Group of Companies Inc.
February 16, 2015 Interpublic Group of Companies Inc. (IPG-NYSE) Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 05/28/2012 Current Price (02/13/15) $22.10
More informationSimon Property Group Inc. (SPG-NYSE) Analyst Note
February 02, 2015 Simon Property Group Inc. (SPG-NYSE) Analyst Note NEUTRAL Current Recommendation Prior Recommendation Underperform Date of Last Change 09/11/2014 Current Price (01/30/15) $198.66 Target
More informationMarathon Petroleum Corporation
January 19, 2015 Marathon Petroleum Corporation (MPC-NYSE) Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 01/07/2014 Current Price (01/16/15) $77.56 Target
More informationSnap-On Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES RECENT NEWS (SNA-NYSE) SUMMARY
February 09, 2015 Snap-On Inc. (SNA-NYSE) NEUTRAL Current Recommendation Prior Recommendation Outperform Date of Last Change 09/26/2011 Current Price (02/06/15) $140.99 Target Price $148.00 SUMMARY Keeping
More informationFirst Republic Bank NEUTRAL ZACKS CONSENSUS ESTIMATES (FRC-NYSE) SUMMARY
March 06, 2015 First Republic Bank Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Neutral Date of Last Change 04/14/2011 Current Price (03/05/15) $57.70 Target Price $61.00 52-Week High
More informationTE Connectivity Ltd. (TEL-NYSE) Analyst Note
January 30, 2015 TE Connectivity Ltd. (TEL-NYSE) Analyst Note Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 12/30/2012 Current Price (01/29/15) $67.57
More informationDillard s Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (DDS-NYSE)
March 12, 2015 Dillard s Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 01/05/2014 Current Price (03/11/15) $130.28 Target Price $137.00 52-Week High
More informationathenahealth Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (ATHN-NASDAQ) SUMMARY
February 10, 2015 athenahealth Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 10/23/2011 Current Price (02/09/15) $136.28 Target Price $143.00 52-Week
More informationPenske Automotive Group, Inc. (PAG-NYSE)
February 13, 2015 Penske Automotive Group, Inc. (PAG-NYSE) Current Recommendation Prior Recommendation Neutral Date of Last Change 07/16/2014 Current Price (02/12/15) $47.96 Target Price $58.00 SUMMARY
More informationAXIS Capital Holdings Ltd.
March 20, 2015 AXIS Capital Holdings Ltd. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 07/24/2013 Current Price (03/19/15) $51.45 Target Price $54.00
More informationFlowserve Corporation
March 17, 2015 Flowserve Corporation Current Recommendation Prior Recommendation Underperform Date of Last Change 12/18/2014 Current Price (03/16/15) $56.96 Target Price $60.00 NEUTRAL (FLS-NYSE) SUMMARY
More informationCONSOL Energy Inc. (CNX-NYSE)
March 17, 2015 CONSOL Energy Inc. (CNX-NYSE) Current Recommendation NEUTRAL Prior Recommendation Underperform Date of Last Change 08/20/2013 Current Price (03/16/15) $27.02 Target Price $28.00 SUMMARY
More informationCabot Oil & Gas Corporation
January 16, 2015 Cabot Oil & Gas Corporation Current Recommendation Prior Recommendation Neutral Date of Last Change 01/16/2015 Current Price (01/15/15) $28.78 Target Price $26.00 UNDERPERFORM SUMMARY
More informationSuncor Energy UNDERPERFORM ZACKS CONSENSUS ESTIMATES (SU-NYSE)
March 11, 2015 Suncor Energy (SU-NYSE) Current Recommendation Prior Recommendation Neutral Date of Last Change 12/18/2014 Current Price (03/10/15) $28.03 Target Price $25.00 UNDERPERFORM SUMMARY Amid weak
More informationGenworth Financial Inc.
February 12, 2015 Genworth Financial Inc. Current Recommendation Prior Recommendation Neutral Date of Last Change 08/22/2014 Current Price (02/11/15) $8.33 Target Price $7.50 SUMMARY DATA UNDERPERFORM
More informationArmstrong World Industries, Inc.
December 11, 2014 Armstrong World Industries, Inc. (AWI-NYSE) Current Recommendation Prior Recommendation Neutral Date of Last Change 08/24/2014 Current Price (12/10/14) $47.71 Target Price $43.00 SUMMARY
More informationMindray Medical International Limited
January 22, 2015 Mindray Medical International Limited Current Recommendation NEUTRAL Prior Recommendation Outperform Date of Last Change 06/26/2014 Current Price (01/21/15) $26.73 Target Price $28.00
More informationSallie Mae NEUTRAL ZACKS CONSENSUS ESTIMATES (SLM-NASDAQ)
December 30, 2014 Sallie Mae (SLM-NASDAQ) Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 01/08/2013 Current Price (12/29/14) $10.32 Target Price $11.00
More informationSymmetry Medical, Inc.
November 28, 2014 Symmetry Medical, Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 11/28/2014 Current Price (11/27/14) $9.11 Target Price $9.50 52-Week
More informationPlum Creek Timber Co. Inc.
February 19, 2015 Plum Creek Timber Co. Inc. Current Recommendation Prior Recommendation Underperform Date of Last Change 11/23/2014 Current Price (02/18/15) $43.04 Target Price $45.00 NEUTRAL (PCL-NYSE)
More informationSinopec Shanghai Petrochemical Co. Ltd.
March 18, 2013 Sinopec Shanghai Petrochemical Co. Ltd. (SHI-NYSE) NEUTRAL Current Recommendation Prior Recommendation Outperform Date of Last Change 06/10/2008 Current Price (03/15/13) $42.10 Target Price
More informationKB Home UNDERPERFORM ZACKS CONSENSUS ESTIMATES (KBH-NYSE)
February 11, 2015 KB Home (KBH-NYSE) Current Recommendation Prior Recommendation Neutral Date of Last Change 02/11/2015 Current Price (02/10/15) $13.61 Target Price $12.00 UNDERPERFORM SUMMARY We are downgrading
More informationTransocean Ltd. NEUTRAL ZACKS CONSENSUS ESTIMATES (RIG-NYSE)
January 14, 2015 Transocean Ltd. (RIG-NYSE) Current Recommendation Prior Recommendation Underperform Date of Last Change 02/14/2012 Current Price (01/13/15) $15.52 Target Price $16.00 NEUTRAL SUMMARY We
More informationZoetis Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (ZTS-NYSE) SUMMARY. Revenue Estimates (In millions of $) Q1 Q2 Q3 Q4 Year (Mar) (Jun) (Sep) (Dec) (Dec)
March 06, 2015 Zoetis Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 06/03/2014 Current Price (03/05/15) $46.46 Target Price $49.00 52-Week High
More informationHudson City Bancorp, Inc.
March 20, 2015 Hudson City Bancorp, Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 03/20/2015 Current Price (03/19/15) $10.31 Target Price $11.00 52-Week
More informationNavigant Consulting Inc.
February 17, 2015 Navigant Consulting Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 08/15/2013 Current Price (02/16/15) $14.99 Target Price $16.00
More informationBed Bath & Beyond Inc.
January 21, 2015 Bed Bath & Beyond Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 11/23/2009 Current Price (01/20/15) $73.31 Target Price $77.00 52-Week
More informationSUMMARY. Risk Level *
February 02, 2015 Xerox Corporation Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 10/18/2012 Current Price (01/30/15) $13.17 Target Price $14.00 52-Week
More informationPrecision Castparts Corp.
February 19, 2015 Precision Castparts Corp. Current Recommendation Prior Recommendation Neutral Date of Last Change 02/19/2015 Current Price (02/18/15) $210.97 Target Price $192.00 UNDERPERFORM (PCP-NYSE)
More informationNuStar Energy, L.P. NEUTRAL ZACKS CONSENSUS ESTIMATES (NS-NYSE) SUMMARY
March 13, 2015 NuStar Energy, L.P. Current Recommendation Prior Recommendation Underperform Date of Last Change 09/26/2013 Current Price (03/12/15) $60.71 Target Price $63.00 NEUTRAL SUMMARY (NS-NYSE)
More informationCompanhia Paranaense De Energia
January 21, 2015 Companhia Paranaense De Energia (ELP-NYSE) Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 01/21/2015 Current Price (01/20/15) $12.20
More informationUbiquiti Networks, Inc.
January 07, 2015 Ubiquiti Networks, Inc. Current Recommendation Prior Recommendation Neutral Date of Last Change 01/07/ 2015 Current Price (01/06/15) $27.86 Target Price $25.00 UNDERPERFORM (UBNT-NASDAQ)
More informationCanadian Natural Resources Ltd.
September 11, 2009 Canadian Natural Resources Ltd. SUMMARY DATA NEUTRAL Current Recommendation Prior Recommendation OUTPERFORM Date of Last Change 08/18/2009 Current Price (09/10/09) $62.91 Target Price
More informationSUMMARY. Risk Level *
March 20, 2015 Aon Plc NEUTRAL Current Recommendation Prior Recommendation Outperform Date of Last Change 06/18/2012 Current Price (03/19/15) $98.91 Target Price $104.00 SUMMARY (AON-NYSE) Aon s fourth-quarter
More informationUnited Parcel Service Inc.
December 25, 2014 United Parcel Service Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 02/04/2009 Current Price (12/24/14) $112.41 Target Price $118.00
More informationEquity Residential NEUTRAL ZACKS CONSENSUS ESTIMATES (EQR-NYSE) SUMMARY
March 16, 2015 Equity Residential Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 11/15/2009 Current Price (03/13/15) $77.02 Target Price $81.00 52-Week
More informationInteractive Brokers Group, Inc.
January 06, 2015 Interactive Brokers Group, Inc. (IBKR-NASDAQ) Current Recommendation NEUTRAL Prior Recommendation Outperform Date of Last Change 07/08/2014 Current Price (01/05/15) $28.88 Target Price
More informationCooper Tire & Rubber Co.
February 12, 2015 Cooper Tire & Rubber Co. Current Recommendation Prior Recommendation Neutral Date of Last Change 08/19/2014 Current Price (02/11/15) $36.75 Target Price $44.00 OUTPERFORM (CTB-NYSE) SUMMARY
More information3M Company NEUTRAL ZACKS CONSENSUS ESTIMATES (MMM-NYSE)
January 29, 2015 3M Company Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 04/27/2010 Current Price (01/28/15) $163.94 Target Price $172.00 52-Week High
More informationBorgWarner Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (BWA-NYSE)
February 13, 2015 BorgWarner Inc. Current Recommendation Prior Recommendation Underperform Date of Last Change 03/24/2013 Current Price (02/12/15) $61.38 Target Price $64.00 NEUTRAL (BWA-NYSE) SUMMARY
More informationExelon Corporation NEUTRAL ZACKS CONSENSUS ESTIMATES (EXC-NYSE) SUMMARY
March 06, 2015 Exelon Corporation Current Recommendation Prior Recommendation NEUTRAL Underperform Date of Last Change 06/28/2009 Current Price (03/05/15) $32.97 Target Price $35.00 (EXC-NYSE) SUMMARY
More informationZACKS CONSENSUS ESTIMATES
March 06, 2015 VIVUS Inc. (VVUS-NASDAQ) Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 03/06/2015 Current Price (03/05/15) $2.87 Target Price $3.00 52-Week
More informationMcDermott International Inc.
January 12, 2015 McDermott International Inc. Current Recommendation NEUTRAL Prior Recommendation Underperform Date of Last Change 03/04/2013 Current Price (01/09/15) $2.85 Target Price $3.00 SUMMARY DATA
More informationSirius XM Holdings Inc.
March 14, 2015 Sirius XM Holdings Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 04/17/2013 Current Price (03/13/15) $3.91 Target Price $4.00 52-Week
More informationDollar Tree Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (DLTR-NASDAQ)
February 26, 2015 Dollar Tree Inc. Current Recommendation Earnings Update: Dollar Tree Tops Q4 Earnings & Sales; Guides FY15 SUMMARY DATA NEUTRAL Prior Recommendation Neutral Date of Last Change 08/21/2011
More informationLegg Mason Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (LM-NYSE)
March 12, 2015 Legg Mason Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 09/22/2013 Current Price (03/11/15) $55.03 Target Price $58.00 52-Week High
More informationCitrix Systems Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (CTXS-NASDAQ) SUMMARY
January 13, 2015 Citrix Systems Inc. Current Recommendation Prior Recommendation Outperform Date of Last Change 7/09/2014 Current Price (01/12/15) $61.15 Target Price $64.00 NEUTRAL SUMMARY (CTXS-NASDAQ)
More informationHealthways Inc. OUTPERFORM ZACKS CONSENSUS ESTIMATES (HWAY-NASDAQ) SUMMARY
October 28, 2014 Healthways Inc. Current Recommendation Prior Recommendation Earnings Update SUMMARY DATA Healthways report Q3 OUTPERFORM Neutral Date of Last Change 08/06/2014 Current Price (10/27/14)
More informationNike Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (NKE-NYSE)
December 31, 2014 Nike Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 12/31/2014 Current Price (12/30/14) $96.88 Target Price $102.00 52-Week High
More information